RU98116126A - Фармацевтический комбинированный препарат из ингибитора натрий-водородного обмена и лекарственных средств для лечения сердечно-сосудистых заболеваний - Google Patents
Фармацевтический комбинированный препарат из ингибитора натрий-водородного обмена и лекарственных средств для лечения сердечно-сосудистых заболеванийInfo
- Publication number
- RU98116126A RU98116126A RU98116126/14A RU98116126A RU98116126A RU 98116126 A RU98116126 A RU 98116126A RU 98116126/14 A RU98116126/14 A RU 98116126/14A RU 98116126 A RU98116126 A RU 98116126A RU 98116126 A RU98116126 A RU 98116126A
- Authority
- RU
- Russia
- Prior art keywords
- medicines
- inhibitor
- sodium
- treatment
- cardiovascular diseases
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 2
- 208000008787 Cardiovascular Disease Diseases 0.000 title 1
- 230000036740 Metabolism Effects 0.000 title 1
- 229940079593 drugs Drugs 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 230000004060 metabolic process Effects 0.000 title 1
- 230000035786 metabolism Effects 0.000 title 1
- XONPDZSGENTBNJ-UHFFFAOYSA-N molecular hydrogen;sodium Chemical compound [Na].[H][H] XONPDZSGENTBNJ-UHFFFAOYSA-N 0.000 title 1
Images
Claims (1)
- Текст формулы заявки в факсимильном виде (см. чертижи).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19737224A DE19737224A1 (de) | 1997-08-27 | 1997-08-27 | Pharmazeutisches Kombinationspräparat aus einem Inhibitor des Natrium-Wasserstoff-Austauschers und einem Arzneimittel zur Behandlung von Herz-Kreislauferkrankungen |
| DE19737224.4 | 1997-08-27 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU98116126A true RU98116126A (ru) | 2000-07-10 |
| RU2227751C2 RU2227751C2 (ru) | 2004-04-27 |
Family
ID=7840257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU98116126/15A RU2227751C2 (ru) | 1997-08-27 | 1998-08-26 | Фармацевтический комбинированный препарат из ингибитора натрий-водородного обмена и лекарственных средств для лечения сердечно-сосудистых заболеваний |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6348476B1 (ru) |
| EP (1) | EP0937464B1 (ru) |
| JP (1) | JP4436940B2 (ru) |
| KR (1) | KR19990023904A (ru) |
| CN (1) | CN1172665C (ru) |
| AR (1) | AR017513A1 (ru) |
| AU (1) | AU738598B2 (ru) |
| BR (1) | BR9803233A (ru) |
| CA (1) | CA2245776A1 (ru) |
| CZ (1) | CZ270998A3 (ru) |
| DE (1) | DE19737224A1 (ru) |
| HK (1) | HK1018211A1 (ru) |
| HR (1) | HRP980464A2 (ru) |
| HU (1) | HUP9801924A3 (ru) |
| IL (1) | IL125913A0 (ru) |
| NO (1) | NO320264B1 (ru) |
| NZ (1) | NZ331533A (ru) |
| PL (1) | PL195566B1 (ru) |
| RU (1) | RU2227751C2 (ru) |
| SK (1) | SK116798A3 (ru) |
| TR (1) | TR199801661A2 (ru) |
| TW (1) | TW589175B (ru) |
| ZA (1) | ZA987723B (ru) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19945302A1 (de) * | 1999-09-22 | 2001-03-29 | Merck Patent Gmbh | Biphenylderivate als NHE-3-Inhibitoren |
| IL147696A0 (en) * | 2001-01-25 | 2002-08-14 | Pfizer Prod Inc | Combination therapy |
| US6423705B1 (en) | 2001-01-25 | 2002-07-23 | Pfizer Inc. | Combination therapy |
| AU2003244430A1 (en) * | 2002-02-04 | 2003-09-02 | Sanofi-Aventis Deutschland Gmbh | Combination preparation of the sodium-hydrogen exchange inhibitor cariporide with ace inhibitors for preventing heart failure and other age-related dysfunctions of organs, age- related diseases and for prolonging lifespan |
| US6844361B2 (en) * | 2002-02-04 | 2005-01-18 | Aventis Pharma Deutschland Gmbh | Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor |
| US7375138B2 (en) | 2002-05-18 | 2008-05-20 | Sanofi-Aventis Deutschland Gmbh | Pentafluorosulfanylbenzoylguanidines, processes for their preparation, their use as medicaments or diagnostic aids, and medicaments comprising them |
| FR2840302B1 (fr) * | 2002-06-03 | 2004-07-16 | Aventis Pharma Sa | Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant |
| US6878748B2 (en) | 2002-06-13 | 2005-04-12 | Aventis Pharma Deutschland Gmbh | Fluorinated cycloalkyl-derivatized benzoylguanidines, process for their preparation, their uses as medicament, and medicament containing them |
| DK1620394T3 (da) * | 2003-05-06 | 2008-11-24 | Merck Patent Gmbh | Fremgangsmåde til krystallisering af guanidinumsalte |
| US7534894B2 (en) | 2003-09-25 | 2009-05-19 | Wyeth | Biphenyloxy-acids |
| DE10356717A1 (de) * | 2003-12-02 | 2005-07-07 | Aventis Pharma Deutschland Gmbh | Verfahren zur Herstellung von (3-Oxo-2,3-dihydro-1H-isoindol-1-yl)-acetylguanidin-Derivaten |
| US7531569B2 (en) * | 2003-12-02 | 2009-05-12 | Sanofi-Aventis Deutschland Gmbh | Process for preparing (3-oxo-2,3-dihydro-1H-isoindol-1-yl) acetylguanidine derivatives |
| US20060159742A1 (en) * | 2004-11-05 | 2006-07-20 | King Pharmaceutical Research & Development, Inc. | Stabilized individually coated ramipril particles, compositions and methods |
| US10517839B2 (en) | 2008-06-09 | 2019-12-31 | Cornell University | Mast cell inhibition in diseases of the retina and vitreous |
| WO2018002673A1 (en) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Novel formulations of angiotensin ii receptor antagonists |
| EP3960165A1 (en) * | 2020-08-25 | 2022-03-02 | Fondation EspeRare | Nhe-1 inhibitors for the treatment of coronavirus infections |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0556673B1 (de) | 1992-02-15 | 1997-09-17 | Hoechst Aktiengesellschaft | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| ES2097409T3 (es) * | 1992-09-22 | 1997-04-01 | Hoechst Ag | Benzoilguanidinas, procedimiento para su preparacion, asi como su empleo como antiarritmicos. |
| DE4328869A1 (de) | 1993-08-27 | 1995-03-02 | Hoechst Ag | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE4421536A1 (de) | 1994-06-20 | 1995-12-21 | Hoechst Ag | Perfluoralkylgruppen tragende phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE4422685A1 (de) | 1994-06-29 | 1996-01-04 | Hoechst Ag | Ortho-amino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE4432106A1 (de) | 1994-09-09 | 1996-03-14 | Hoechst Ag | Mit Heterocyclen-N-Oxid-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum, sie enthaltendes Medikament sowie Zwischenprodukte zu ihrer Herstellung |
| DE19741635A1 (de) * | 1997-09-22 | 1999-03-25 | Hoechst Marion Roussel De Gmbh | Biphenylsulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament |
-
1997
- 1997-08-27 DE DE19737224A patent/DE19737224A1/de not_active Withdrawn
-
1998
- 1998-08-21 EP EP98115754A patent/EP0937464B1/de not_active Expired - Lifetime
- 1998-08-24 IL IL12591398A patent/IL125913A0/xx not_active IP Right Cessation
- 1998-08-25 TR TR1998/01661A patent/TR199801661A2/xx unknown
- 1998-08-25 SK SK1167-98A patent/SK116798A3/sk unknown
- 1998-08-25 AR ARP980104222A patent/AR017513A1/es unknown
- 1998-08-25 NZ NZ331533A patent/NZ331533A/xx unknown
- 1998-08-25 BR BR9803233-0A patent/BR9803233A/pt not_active Application Discontinuation
- 1998-08-25 CZ CZ982709A patent/CZ270998A3/cs unknown
- 1998-08-25 CA CA002245776A patent/CA2245776A1/en not_active Abandoned
- 1998-08-26 NO NO19983926A patent/NO320264B1/no unknown
- 1998-08-26 HR HR19737224.4A patent/HRP980464A2/hr not_active Application Discontinuation
- 1998-08-26 RU RU98116126/15A patent/RU2227751C2/ru not_active IP Right Cessation
- 1998-08-26 AU AU81908/98A patent/AU738598B2/en not_active Ceased
- 1998-08-26 ZA ZA987723A patent/ZA987723B/xx unknown
- 1998-08-26 HU HU9801924A patent/HUP9801924A3/hu unknown
- 1998-08-26 CN CNB981187013A patent/CN1172665C/zh not_active Expired - Fee Related
- 1998-08-26 JP JP24020398A patent/JP4436940B2/ja not_active Expired - Fee Related
- 1998-08-27 KR KR1019980034758A patent/KR19990023904A/ko not_active Application Discontinuation
- 1998-08-27 PL PL328251A patent/PL195566B1/pl unknown
- 1998-10-07 TW TW087113939A patent/TW589175B/zh not_active IP Right Cessation
-
1999
- 1999-07-28 HK HK99103247A patent/HK1018211A1/xx not_active IP Right Cessation
-
2000
- 2000-07-05 US US09/610,425 patent/US6348476B1/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU98116126A (ru) | Фармацевтический комбинированный препарат из ингибитора натрий-водородного обмена и лекарственных средств для лечения сердечно-сосудистых заболеваний | |
| EE200000395A (et) | Peroraalne farmatseutiline pulseeriva vabanemisega annusvorm | |
| DE122010000011I1 (de) | Flüssige gonadotropinhaltige Arzneimittel | |
| NO993315D0 (no) | Raskt frigjörende og smaksmaskerende farmasöytisk doseringsform | |
| DE69513671D1 (de) | Arzneimittel | |
| DZ2494A1 (fr) | Composition pharmaceutique d'oméprazole. | |
| NO20020090L (no) | Farmasöytiske og n¶ringsformuleringer inneholdende essensielle fettsyrer og homocystein-senkende midler | |
| DE69618587D1 (de) | Chinazoline und pharmazeutische zusammensetzungen | |
| NO953657D0 (no) | Nytt farmasöytisk produkt | |
| DE69629755D1 (de) | Irbesartanhaltiges Arzneimittel | |
| BR9500784A (pt) | Composto e formulação farmacêutica | |
| DE69525148D1 (de) | Pharmazeutische formulierung | |
| NO995565L (no) | Farmasöytiske formuleringer inneholdende vorikonazol | |
| DE69828895D1 (de) | Alpha-aryl-n-alkylnitrone sowie diese enthaltende pharmazeutische zubereitungen | |
| DE69300913D1 (de) | Polymorph Terazosin und pharmazeutische Zusammenstellung. | |
| NO305903B1 (no) | Benzonitriler og benzofluorider, legemidler bestående av forbindelsene, farmasöytiske preparater inneholdende forbindelsene, samt anvendelse av forbindelsene for fremstilling av farmasöytiske preparater | |
| EE9600139A (et) | Farmatseutilised preparaadid ja ravimid endoteelsete düsfunktsioonide vältimiseks ja raviks | |
| DZ2539A1 (fr) | Compositions pharmaceutiques pour le traitement dela résistance à l'insuline. | |
| ATE240720T1 (de) | Paracetamol enthaltende schlickbare tablette | |
| NO983926D0 (no) | Farmasöytisk kombinasjonspreparat av en inhibitor av natrium-hydrogen-veksler og et legemiddel for behandling av hjertekretslöpsykdommer | |
| DE69524592D1 (de) | 2-Acylaminopropanolverbindung und ihre pharmazeutische Zusammensetzung | |
| DZ1926A1 (fr) | Formulations pharmaceutiques. | |
| ITRM920222A0 (it) | Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari. | |
| FI964619A0 (fi) | Epilepsialääkkeiden iholle annostelu | |
| NO993784D0 (no) | Farmasöytiske blandinger inneholdende ibuprofen og domperidon for behandling av migrene |